Journal of Nuclear Medicine. The new fibroblast activation protein inhibitor radiotracer was created by adding a molecule to the compound so that it binds longer to the FAPI protein in tumors, researchers said."/> Journal of Nuclear Medicine. The new fibroblast activation protein inhibitor radiotracer was created by adding a molecule to the compound so that it binds longer to the FAPI protein in tumors, researchers said."/> Researchers create radiotracer with stronger tumor uptake

Researchers create radiotracer with stronger tumor uptake

2021-09-28

Researchers said the tumor uptake of a new PET radiotracer, gallium-68 DOTA-2P (FAPI)2, was about two-fold stronger than Ga-68 FAPI-46 in patient-derived xenografts, according to a study published in Journal of Nuclear Medicine. The new fibroblast activation protein inhibitor radiotracer was created by adding a molecule to the compound so that it binds longer to the FAPI protein in tumors, researchers said.

Full story:

SNMMI SmartBrief

Nuclear medicine, molecular imaging and therapy

Designed specifically for nuclear medicine and molecular imaging professionals, SNMMI SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession.